Food Allergies - undeclared allergensIf you suspect that there is an undeclared allergen in a food, contact MPI Food Safety on 0800 00 83 33, or by email: firstname.lastname@example.org.
For more details go to MPI Food Safety here
Information on potential food allergens that must be declared on food labels or made available to you if you ask for it. See the Food Smart website here
24 March 2020
Thank you for visiting the Allergy New Zealand website. If you have an emergency, please leave this site and phone 111.
Our Auckland office is closed until further notice.
Allergy New Zealand is now working remotely to reduce current health risks to our staff and volunteers, and there will be delays in clearing voice and email messages. Alternatively, you can email enquiries to email@example.com. Please also continue to check this website, our Facebook page and www.health.govt.nz for updates.
FOOD RECALL – undeclared allergen – PEANUTS
Eta Chocolate Raisins due to the possible presence of chocolate coated peanuts.
This recall is only related to a specific batch which has been sold in specific stores in the North Island. The details of the recall are in the below link.
The FundaPen™ campaign, which last year saw hundreds of free EpiPens® given to children in need, has been extended for a limited time to any New Zealander at risk of anaphylaxis.
While funded stocks last, Allergy New Zealand and Pub Charity are offering the auto-injector pens to anyone who is doctor-diagnosed as being at risk of anaphylaxis. EpiPen® (adrenaline autoinjector pens), which last only 12 – 18 months, are not funded by Pharmac and can cost anywhere between $120 and $350 each.
To receive a free EpiPen®, people who have been diagnosed as at risk of anaphylaxis, should talk to their General Practitioner, who will be able to order it through Allergy Pharmacy. The pens will be allocated on a ‘first-come, first-served basis’ until the remaining funding runs out. Allergy NZ does not receive any financial benefit from the FundaPen™ initiative.
PHOs have been providing General Practices with information about FundaPen™. Pegasus Health General Practices can find the information on Health Pathways.
Pub Charity last year donated $300,000 to increase the availability of EpiPen auto-injectors for allergy sufferers who are doctor-diagnosed as at risk of anaphylaxis such as to food, or bee or wasp venom. Allergy NZ will continue to seek funding to sustain the FundaPen™ initiative as long as possible.
Allergy NZ Chief Executive Mark Dixon says the organisation is very grateful to Pub Charity for making this initiative possible. “Together we wanted to raise awareness of this issue and ensure as many eligible people as possible benefited from FundaPen™,” he says.
The collaboration with Pub Charity, followed eight attempts in the last 15 years to have EpiPen® auto-injectors publicly funded through PHARMAC. “We continue to hope that EpiPens® will eventually become publicly funded as they are in Australia,” Mark says. “We have been doing all we can, and while FundaPen™ is by no means the ideal way, we hope the initiative will help many New Zealanders in the short term.”
Once all the fully-funded FREE EpiPen® auto-injector pens have been dispensed from Allergy Pharmacy, regular prescribing protocols, distribution and fees will apply.
There have been a number of recalls of pesto products in New Zealand and Australia due to the presence of an undeclared allergen (peanuts).
Recalls of affected products in New Zealand can be found on the Ministry for Primary Industries website at: https://www.mpi.govt.nz/food-safety/food-recalls/recalled-food-products/
This issue is not isolated to New Zealand and Australia and follows recalls in Europe and the United Kingdom of pesto products that were manufactured in Italy using internationally sourced ingredients. Current information suggests that the cashew nuts imported into Italy were contaminated with peanuts.
To date there are no known reports of allergic reactions associated with the recalled pesto products in New Zealand.
The Ministry for Primary Industries is working with food safety agencies around the world via the International Food Safety Authorities Network (INFOSAN) to monitor developments. Investigations are ongoing to confirm that this issue has been contained.
Consumers with a peanut allergy are advised to be cautious when purchasing products containing cashew nuts. Consumers with allergies should always read ingredient information on labels and always avoid products with a precautionary allergen statement such as 'may contain' or 'may be present' in relation to peanuts in food products containing cashews.
Allergy New Zealand advises If you are allergic to peanuts and you have an allergic reaction to a product containing cashew, follow your Anaphylaxis Action Plan and as soon as you are able, report this to MPI Food Compliance on 0800 00 83 33, or by email: firstname.lastname@example.org.
Latest food recalls
Allergy Today e-newsletterOur March issue of the Allergy Today e-newsletter is available here. If you would like to subscribe to receive future issues click here.
See past issues:
Pollen CalendarFREE Annual Pollen Calendar
Download your very own copy here
Nip Allergies in the BubSee the latest advice on Allergy prevention from Australia's National Allergy Strategy here.
2018 Food Allergen Labelling GuideThere are now 10 food allergens which must be declared on labels, and/or information provided on food for sale. Allergy New Zealand’s 2018 Food Allergen Labelling Guide is available here.
Guide to ACC Cover for Allergic Reactions (Anaphylaxis)January 2018
The ACC guide, developed in consultation with Allergy New Zealand and Allergy specialists, is now available online here
For more information on anaphylaxis, and advice on ACC claims, go here
Hospitality training video27 July, 2016
Aimed at front-of-house staff, this video describes steps to take in serving a customer with food allergies.
Find more information here.
Anaphylaxis Campaign - #takethekit
Our friends at Anaphylaxis Campaign have recently released a hard-hitting short film to alert severely allergic young people to the importance of carrying their Adrenaline Auto-Injector (AAI), the first line of treatment for anaphylaxis. Watch the video here.